Skip to main content

Advertisement

SpringerLink
Log in

Infections in acute myeloid leukemia: an analysis of 382 febrile episodes

  • Original paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Neutropenic fever is an important cause of morbidity and mortality during therapy of acute myeloid leukemia (AML). We retrospectively analyzed 382 febrile episodes encountered during induction and consolidation chemotherapy to determine the potential etiology, microbiologic spectrum, response/resistance to antibiotics and outcome. Between May, 2001 and December, 2006, 95 patients with de novo non-M3 AML received remission induction chemotherapy followed by consolidation in those who achieved complete remission. Patients median age was 28 years, ranging from 2 to 61 years, 26 patients were ≤15 years of age. There were 57 males and 38 females. Febrile neutropenia was defined as per international guidelines. A total of 382 febrile episodes were recorded; neutropenic 347 (induction phase 172, consolidation phase 175) and non-neutropenic 35 (induction 16, consolidation 19). Clinical, microbiological and radiological evidence of infection could be identified in 64% of the febrile episodes (74% during induction, 52% during consolidation). Pulmonary infections were most common, both during induction and consolidation phase. Microbiologically gram-negative infections predominated. There were 60 possible/probable/definite episodes of fungal infection. Six cases of tuberculosis (pulmonary 5 and spine 1) and 3 cases of malaria (including one case of cerebral malaria) were also identified. Nineteen patients died (17 during induction, 2 during consolidation); 17 deaths were infection related, 12/17 possibly due to fungal infections. We suggest that evaluation of antibacterial resistance patterns in an institution must be done routinely in order to choose empiric antibiotics therapy. Careful selection of antibiotics and early institution of antifungal therapy besides considering alternative diagnosis peculiar to the region (e.g. tuberculosis, malaria) may help in reducing morbidity and mortality during AML therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new direction for its management. Cancer. 2004;100:228–37.

    Article  PubMed  Google Scholar 

  2. Gerson SL, Talbot GH, Hurwitz S, et al. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984;100:345–51.

    CAS  PubMed  Google Scholar 

  3. Hughes WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730–51.

    Article  PubMed  Google Scholar 

  4. National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobial disk susceptibility tests, approved standard. 7th ed. Villanova, PA: NCCLS; 2000. (document M2–A7).

    Google Scholar 

  5. Ascioglu S, Rex RH, de Pauw B, et al. Invasive fungal infections: cooperative group of the european organization for research and treatment of cancer; mycoses study group of the national institute of allergy and infectious diseases. Defining opportunistic invasive fungal infections in immune-compromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7–14.

    Article  CAS  PubMed  Google Scholar 

  6. Jagarlamudi R, Kumar L, Kochupillai V, et al. Infections in acute leukemia: an analysis of 240 febrile episodes. Med Oncol. 2000;17:111–6.

    Article  CAS  PubMed  Google Scholar 

  7. Kumar L, Kochupillai V, Bhujwala RA. Infections in acute myeloid leukemia study of 184 episodes. J Assoc Phys India. 1992;40:18–20.

    CAS  Google Scholar 

  8. Zittoun R, Suciu S, Mandelli F, et al. Granulocyte–macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European organization for research and treatment of cancer and leukemia cooperative group. J Clin Oncol. 1996;14:2150–9.

    CAS  PubMed  Google Scholar 

  9. de Lalla F. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Drugs. 1997;53:789–803.

    Article  PubMed  Google Scholar 

  10. Godwin JE, Kopecky JK, Head DR, et al. A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031). Blood. 1998;91:3607–15.

    CAS  PubMed  Google Scholar 

  11. Witz F, Sadoun A, Perrin MC, et al. A placebo-controlled study of recombinant human granulocyte–macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Blood. 1998;91:2722–30.

    CAS  PubMed  Google Scholar 

  12. Heil G, Hoelzer D, Sanz MA, et al. A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. Blood. 1997;90:4710–8.

    CAS  PubMed  Google Scholar 

  13. Malagola M, Peli A, Damiani D, et al. Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 years treated with induction regimens including fludarabine: retrospective analysis of 224 cases. Euro J Haematol. 2008;81:354–63.

    CAS  Google Scholar 

  14. Cornet M, Fleury L, Maslo C, et al. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. Invasive aspergillosis surveillance network of the assistance Publique-Hopitaux de Paris. J Hosp Infect. 2002;51:288–96.

    Article  CAS  PubMed  Google Scholar 

  15. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91:1068–75.

    PubMed  Google Scholar 

  16. Lehrnbecher T, Varwig D, Kaiser J, et al. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia. 2004;18:72–7.

    Article  CAS  PubMed  Google Scholar 

  17. Offidani M, Corvatta L, Malerba L, et al. Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study. Cancer. 2004;101:567–77.

    Article  PubMed  Google Scholar 

  18. Klastersky J, Ameye L, Maertens J, et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents. 2007;30(Suppl 1):S51–9.

    Article  CAS  PubMed  Google Scholar 

  19. Cherif H, Kronvall G, Björkholm M, et al. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J. 2003;4:420–6.

    Article  PubMed  Google Scholar 

  20. Wisplinghoff H, Seifert H, Wenzel RP, et al. current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Inf Dis. 2003;36:1103–10.

    Article  Google Scholar 

  21. Morris PG, Hassan T, McNamara M, et al. Emergence of MRSA in positive blood cultures from patients with febrile neutropenia—a cause for concern. Support Care Cancer. 2008;16(9):1085–8.

    Article  PubMed  Google Scholar 

  22. Cruciani M, Rampazzo R, Malena M, et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta analysis. Clin Inf Dis. 1996;23:795–805.

    CAS  Google Scholar 

  23. Engels EA, Lau J, Barza M. Efficacy of quinolone prophylaxis in neutropenic patients: a meta analysis. J Clin Oncol. 1998;16:1179–87.

    CAS  PubMed  Google Scholar 

  24. Rubio M, Palau L, Vivas JR, et al. Predominance of gram positive micro-organisms as a cause of septicemia in patients with hematologic malignancies. Infect Control Hosp Epidemiol. 1994;15:101–4.

    Article  CAS  PubMed  Google Scholar 

  25. Gardner A, Mattiuzzi G, Faderl S, et al. Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol. 2008;26(35):5684–8.

    Article  PubMed  Google Scholar 

  26. Sanpakit K, Phuakpet K, Veerakul G, et al. Evaluation of guideline for treatment of febrile neutropenia in pediatric cancer at Siriraj Hospital. J Med Assoc Thai. 2005;88(Suppl 8):S124–34.

    PubMed  Google Scholar 

  27. Paul M, Gafter-Gvili A, Leibovici L, et al. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988–2004. Isr Med Assoc J. 2007;9:424–9.

    PubMed  Google Scholar 

  28. Kitamura K, Takaku F, Miyazaki T, et al. Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders. Jpn J Antibiot. 1991;44:979–86.

    CAS  PubMed  Google Scholar 

  29. Fukuda M, Hirashima K. Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders. Jpn J Antibiot. 1993;46:912–7.

    CAS  PubMed  Google Scholar 

  30. Takashima T, Tsuda S, Misawa S, et al. A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases. Jpn J Antibiot. 1993;46:251–8.

    CAS  PubMed  Google Scholar 

  31. Toyama K, Torii Y, Aoki I, et al. Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders. Jpn J Antibiot. 1992;45:1003–8.

    CAS  PubMed  Google Scholar 

  32. Kawai Y, Ueda T, Iwasaki H, et al. Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy. Jpn J Antibiot. 1994;47:1196–201.

    CAS  PubMed  Google Scholar 

  33. Worth LJ, Thursky KA, Seymour JF, et al. Slavin M A Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Hematol. 2007;79:226–33.

    Article  Google Scholar 

  34. Todeschini G, Tecchio C, Borghero C, et al. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies. J Infect. 2006;53:266–73.

    Article  PubMed  Google Scholar 

  35. Kapur D, Dorsky D, Feingold JM, et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2000;25:147–52.

    Article  CAS  PubMed  Google Scholar 

  36. Poutsiaka DD, Skiffington S, Miller KB, et al. Daptomycin in the treatment in the treatment of vancomycin resistant Enteroccus faecium bacteremia in neutropenic patients. J Infect. 2007;54:567–71.

    Article  PubMed  Google Scholar 

  37. Smith PF, Birmingham MC, Noskin GA, et al. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant gram-positive infections in cancer patients with neutropenia. Ann Oncol. 2003;14:795–801.

    Article  CAS  PubMed  Google Scholar 

  38. Linden PK, Moellering RC, Wood CA, et al. Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin. Clin Inf Dis. 2001;33:1816–23.

    Article  CAS  Google Scholar 

  39. Shawgi S, Kumar L, Kochupillai V, et al. Evaluation of pulmonary infiltrates in patients with hematological malignancies using fibreoptic bronchoscopy and bronchoalveolar lavage. Ind J Med Pediatr Oncol. 2004;25:10–21.

    Google Scholar 

  40. Koskenvuo M, Mattanen M, Rahiala J, et al. Respiratory viral infections in children with leukemia. Pediatr Infect Dis J. 2008;27(11):974–80.

    Article  PubMed  Google Scholar 

  41. Mishra P, Kumar R, Mahapatra M, et al. Tuberculosis in acute leukemia: a clinico-hematological profile. Hematology. 2006;11:335–40.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Dr Aarti Kapil of Microbiology Department, AIIMS, gave useful suggestions.

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110029, India

    Ajay Gupta, Mansher Singh, Harkirat Singh, Lalit Kumar, Atul Sharma, Sameer Bakhshi, Vinod Raina & Sanjay Thulkar

  2. Department of Radio-Diagnosis, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110029, India

    Sanjay Thulkar

Authors
  1. Ajay Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mansher Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Harkirat Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lalit Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Atul Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sameer Bakhshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vinod Raina
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sanjay Thulkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lalit Kumar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, A., Singh, M., Singh, H. et al. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol 27, 1037–1045 (2010). https://doi.org/10.1007/s12032-009-9330-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-009-9330-9

Keywords

Search

Navigation